mRNA Analytical&Quality Testing

The function of cap structure and capping efficiency detection

The structure of mRNA mainly includes the 5' cap , the 5' untranslated region (UTR), and the open reading frame (ORF), 3' end untranslated region and Poly(A) tail. All mature eukaryotic mRNA have a methylguanosine cap (m7G) structure at the 5' end. Capping can help mRNA be smoothly transported out of the nucleus, increase mRNA stability, prevent it from being degraded by ribonuclease, and is crucial for protein expression.


At present, the main method used is to first synthesize a probe containing biotin that matches the first 50nt of the 5'UTR region, let the probe bind to mRNA, then perform enzyme cleavage with RNase H, enrich the probe with the 5’ cleavage products using streptavidin magnetic beads specifically, and finally eluted in water . The purified 5’ cleavage products are visualized using mass spectrometry(LC-MS).


The role of Poly(A) structure and Poly(A) distribution detection principle

Eukaryotic mRNAs often terminate with a stretch of adenosines on their 3′ end which can vary in length from 20 to over 200 bases depending on the species.

It has been postulated that longer tails increase translation efficiency, provide mRNA stability, and can possibly affect immune response although there has been some recent research suggesting that tail length of mRNA and translation efficiency are linked only during specific cell development stages。

At present, RNase T1 is mainly used for enzyme digestion, and the polyA fragments after enzyme digestion are enriched with Oligo DT. After elution, the polyA fragments enriched on the filler are entered into LC-MS for analysis.

Third-party testing services

Quality control is one of the most important aspects of drug development,Hzymes provides third-party quality control services for mRNA drugs.

■  Self-established quality control analysis platform                      ■  mRNA capping efficiency detection              ■  mRNA Poly(A) distribution detection

■  Plasmid analysis method development and validation              ■  Development and validation of analytical methods for LNP component content analysis                             

■  Product and process impurity studies                                        ■  Raw and auxiliary materials testing               ■  One-stop CMC solution

Beverly M.; Dell A.; Parmar P.; Houghton L. Label-free analysis of mRNA capping efficiency using RNase H probes and LC-MS. Anal. Bioanal. Chem. 2016, 408 (18), 5021–5030. 10.1007/s00216-016-9605-x.
Requirement Confirmation
Contract Confirmation
Project Implantation
Output Report
- DELIVERY STANDARDS -


Service items


Periodicity(Working days)

Deliverables

Criteria

Probe Design & synthesis

5

Probe

Determined by customer requirement

Capping efficiency Detection

3-10

Detection report

Poly(A) distribution detection
3-10Detection report
- CASE -
·Cap rate detection·
·Poly (A) distribution detection·
· Capping efficiency detection molecular weight matching table ·

Name

Response

Observed  

mass (Da)

Expected 

mass (Da)

Mass error

 (mDa)

Mass error

 (ppm)

%Cap1

Monphos

38908

7004.385

7004.297

88.1

12.6

95.1%

Triphos

1052878

7164.479

7164.256

223.1

31.1

Triphos_a

506256

6835.276

6835.05

225.3

33.0

Diphos_a

101498

6755.327

6755.071

256.5

38.0

cap1

23880426

7471.694

7471.551

143.2

19.2

cap1_gaa

1924043

6468.059

6467.933

125.6

19.4

cap1_a

5077712

7142.483

7142.345

138.5

19.4

cap1_aa

2301145

6813.278

6813.139

139.1

20.4

- SERVICE ORDERING -
MRNA vaccines and drug-related services
Recombinant Protein
Expression CRDMO Services
Biopharmaceutical raw materials and quality control reagent kits
Service subscription
Website & Brochure
© 2023 Hzymes Biotechnology Co., Ltd. All rights reserved
Powered by Feedback Manage